BNTC R&D Expense Growth
Benitec Biopharma Inc · R&D Expense Growth
BNTC R&D Expense Growth
Latest reported27.58%period ending
BNTC FY R&D Growth (YoY) (0.00% → 27.58%)
Latest values, visible window
High-resolution chart · PNG
BNTC r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 27.5802% | |
| 17.4451% | |
| 22.1935% | |
| 13.3251% | |
| 60.5698% | |
| 133.922% | |
| -5.9993% | |
| -14.3075% | |
| -8.5421% | |
| -44.9743% | |
| 103.7949% | |
| -34.0581% | |
| 73.7707% | |
| 137.6451% | |
| 13.1206% | |
| -6.6598% | |
| 21.69% | |
| 87.0623% | |
| 0% | |
| -100% | |
| -27.4481% | |
| 194.8426% | |
| 0% |